Bevacizumab

Title: Bevacizumab for the treatment of colorectal cancer. Pre-Clinical study completed. Materials for Phase III studies 200gms generated at 500 L scale

Innovator: Vitane Biologics Private Limited(EPR Centre for Cancer Research and Bioinformatics)

Bevacizumab for the treatment of colorectal cancer. Pre-Clinical study completed. Materials for Phase III studies 200gms generated at 500 L scale
  • Innovator's Name
  • Product/Technology Description

Vitane Biologics Private Limited(EPR Centre for Cancer Research and Bioinformatics)

  • Product Name: Bevacizumab
  • Product Title: Bevacizumab for the treatment of colorectal cancer. Pre-Clinical study completed. Materials for Phase III studies 200gms generated at 500 L scale
  • Description: Bevacizumab for the treatment of colorectal cancer. Pre-Clinical study completed. Materials for Phase III studies 200gms generated at 500 L scale
Color: